EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 3.0

Comparative Efficacy of First-Line versus Further-Line Icotinib Therapy in Advanced Lung Adenocarcinoma: A Real-World Cohort Study

Xueli Zhang, Junhui Wang iD, Jianxin Chen iD

OncoTargets and Therapy · 2026-10 · Volume 19 · 1-10

DOI: 10.2147/ott.s634040 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift OncoTargets and Therapy, 2026-10. Verfasst von Xueli Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Quzhou People's Hospital, The Quzhou Affiliated Hospital, Wenzhou Medical University, Quzhou, Zhejiang, People's Republic o…. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

EGFR-TKIicotiniblung adenocarcinomareal-world evidencetreatment sequencing

Autor:innen und Institutionen

  • Department of Pediatrics, Quzhou People's Hospital, The Quzhou Affiliated Hospital, Wenzhou Medical University, Quzhou, Zhejiang, People's Republic of China.
  • Department of Medical Oncology, Quzhou People's Hospital, The Quzhou Affiliated Hospital, Wenzhou Medical University, Quzhou, Zhejiang, People's Republic of China.
  • Department of Radiation, Quzhou People's Hospital, The Quzhou Affiliated Hospital, Wenzhou Medical University, Quzhou, Zhejiang, People's Republic of China.
  • Department of International Ward, Quzhou People's Hospital, The Quzhou Affiliated Hospital, Wenzhou Medical University, Quzhou, Zhejiang, People's Republic of China.

ORCID-Profile: Junhui Wang, Jianxin Chen

Zitieren

APA

Zhang, X., Wang, J., & Chen, J. (2026). Comparative Efficacy of First-Line versus Further-Line Icotinib Therapy in Advanced Lung Adenocarcinoma: A Real-World Cohort Study. OncoTargets and Therapy, Volume 19, 1-10. https://doi.org/10.2147/ott.s634040

Vancouver

Zhang X, Wang J, Chen J. Comparative Efficacy of First-Line versus Further-Line Icotinib Therapy in Advanced Lung Adenocarcinoma: A Real-World Cohort Study. OncoTargets and Therapy. 2026;Volume 19:1-10. doi:10.2147/ott.s634040

BibTeX
@article{Zhang2026,
  author = {Zhang, Xueli and Wang, Junhui and Chen, Jianxin},
  title = {Comparative Efficacy of First-Line versus Further-Line Icotinib Therapy in Advanced Lung Adenocarcinoma: A Real-World Cohort Study},
  journal = {OncoTargets and Therapy},
  year = {2026},
  volume = {Volume 19},
  pages = {1--10},
  doi = {10.2147/ott.s634040}
}
Kostenlos starten →